This site contains promotional information intended only for healthcare professionals resident in Great Britain 
Sign in
Sign In or Register
Sign out

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Explore Content

For Inflectra® (infliximab) Prescribing Information for Great Britain click here.
Adverse event reporting information can be found at the bottom of the page.

Biosimilars overview

What is a biosimilar

The future of biosimilars

Considerations for biologic switching

Adoption and use of biosimilars may help increase choice and potentially drive cost savings by stimulating competition between orginator biologics and their respective biosimilars as well as between biosimilars themselves.1

A competitive and sustainable marketplace that supports both the orginator biologics and biosimilars is necessary to obtain the benefits that those important medicines offer for patients, physicians, payers and healthcare systems.2

Watch our video to learn more:

Optimising treatment with Inflectra

Learn more about TDM and biomarkers

Learn more
References
  1. NICE. Biosimilar Medicines. [online]. 2016[viewed: February 2021]. Available from: https://www.nice.org.uk/advice/ktt15/resources/biosimilar-medicines-pdf-58757954414533.
  2. IMS Institute for Healthcare Informatics. Delivering on the Potential of Biosimilar Medicines, The Role of Functioning Competitive Markets. 2016[viewed: February 2021]. Available from: http://medicinesforeurope.com/wp-content/uploads/2016/03/IMS-Institute-Biosimilars-Report-March-2016-FINAL.pdf.
PP-IFA-GBR-0497. September 2021

Quick Links

  • Inflammatory bowel disease

  • Infliximab mechanism of action

  • Support & Resources

Learn about the evidence supporting the use of Inflectra in patients with rheumatoid arthritis.

Find out more

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

Yes

No

OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.

If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.

Would you like to register or sign in now?